Stock Forecast Chart
Stock Price Prediction Summary
Forecast Score Based on 2 Weeks
Based on our forecast, the price of CUE will rise by +3.89% over the next 2 Weeks and hit $15.31 by Thursday, May 14, 2026. In that time frame, CUE's share price is expected to range between $11.59 and $19.36.
BearishAverageBullish| Date | Predicted Lower | Predicted | Predicted Upper |
|---|---|---|---|
| May 14, 2026 | 11.59 | 15.31 | 19.36 |
| May 13, 2026 | 11.61 | 15.33 | 19.00 |
| May 12, 2026 | 12.93 | 16.41 | 20.53 |
| May 11, 2026 | 13.40 | 17.12 | 21.00 |
| May 8, 2026 | 11.11 | 15.01 | 18.51 |
| May 7, 2026 | 10.49 | 14.59 | 18.56 |
| May 6, 2026 | 10.75 | 14.61 | 18.37 |
| May 5, 2026 | 11.72 | 15.68 | 19.58 |
| May 4, 2026 | 12.49 | 16.39 | 20.18 |
| May 1, 2026 | 10.39 | 14.28 | 18.25 |
CUE shares rose +106.38% in Friday, May 1, 2026's trading session, rising from a previous close of $14.74 to move at $30.42. The stock demonstrated notable intraday movement (see CUE's key stats for a full breakdown), fluctuating between $25.95 and $38.00, a +46.44% trading range. While recent weeks have seen some volatility, CUE has managed to secure a +4,844.73% gain over the past 2 weeks. The upward price movement was accompanied by increased trading volume, with approximately 476.73K shares changing hands, 391.52K more than the previous session. This amounted to $14.50M in total market activity.
Will CUE Continue Its Downward Trend?
According to analyst ratings and projections for CUE, Cue Biopharma, Inc. shares are anticipated to decrease by -57.15%, potentially reaching $19.36 per share by May 14, 2026. Short-term technical indicators currently suggest a neutral sentiment for CUE. For deeper insights, view our sentiment analysis on AAPL covering social and institutional perspectives. However, the stock has recorded 14 positive trading days within the past 30 sessions. Based on the CUE stock forecast, now is not the best time to buy CUE stock because its current trading price is +98.64% above our predicted value, hinting at a possible undervaluation. For deeper insights, view our sentiment analysis on CUE covering social and institutional perspectives.
CUE Technical Momentum: Overbought, Oversold, or Neutral?
An analysis of Relative Strength Index (RSI) indicators provides insight into CUE's momentum. Short-term RSIs (9, 14, and 20-day figures ranging from 67.89% to 72.86%) indicate the stock is leaning toward a strong bullish momentum phase. The 50-day RSI, at 62.12%, suggests strong medium-term momentum. However, the 100-day RSI, at 56.17%, maintains a neutral outlook for the long term. Insights into CUE's shareholder base show how institutional investors are positioning themselves during these momentum shifts
Cue Biopharma Short-Term Forecasts
CUE Forecast For Next 5 Days
Our algorithm anticipates Cue Biopharma (CUE) stock could hit $4.64 by May 08, 2026. This represents a -84.76% fall from today's price, following a -13.36% change over the past five days.
CUE Forecast For Next 30 Days
Based on analysis of market trends, the outlook for Cue Biopharma, Inc. (CUE) stock over the next 30 days is largely negative. Price forecasts suggest an average target of $18.93, which would mean a -37.77% decrease from the current price of $30.42. Projections for this period range from a high of $44.75 to a low of $1.94.
CUE Forecast For Next 90 Days
Our proprietary market analysis suggests predictions for Cue Biopharma's price over the next three months point to a rise. CUE stock is expected to peak at $58.64 on Jul 20, 2026 after potentially dipping to $27.99 on May 21, 2026. On average, CUE is likely to trade around $38.03 in the coming 90 days.
Cue Biopharma Stock Forecast 2025
Based on our predictive models, Cue Biopharma (CUE) is expected to trade between $26.49 and $87.64 throughout 2026. This would result in an average price of $47.36, potentially offering investors a +55.69% return from current levels.
Cue Biopharma, Inc. Monthly Forecast 2026–2027
May 2026
According to our latest forecast models, Cue Biopharma, Inc. (CUE) is positioned to show a strong performance in May 2026. The price is predicted to move between $27.99 and $32.67, settling at an average of $30.52. This could translate to a +0.33% gain.
June 2026
Based on current market signals, Cue Biopharma, Inc. is projected to trend june 2026. We forecast a trading range from $29.17 to $36.35, with a likely average price of $31.62. Investors could expect a potential return of +3.94%.
July 2026
Our predictive algorithms indicate Cue Biopharma, Inc. stock may see a shift in July 2026. The expected range spans $36.14–$58.64, with an average target of $50.69. This represents a positive outlook and a possible gain of +66.63%.
August 2026
Analyzing established trends, Cue Biopharma, Inc. looks set to move in August 2026. Projections place the stock between $29.32 and $45.80, averaging around $38.10. This suggests a +25.25% gain from current levels.
September 2026
Market indicators suggest Cue Biopharma, Inc. could experience notable changes during September 2026. Prices could fluctuate within $26.49 to $84.74, with a midpoint forecast of $45.62. The stock might deliver a +49.97% gain.
October 2026
Forecasting for October 2026, models estimate that Cue Biopharma, Inc. may undergo key fluctuations. If trends hold, the stock might trade between $55.31 and $74.10, averaging $60.44. This signals a positive trajectory with potential returns around +98.69%.
November 2026
According to our latest forecast models, Cue Biopharma, Inc. (CUE) is positioned to show a strong performance in November 2026. The price is predicted to move between $42.64 and $87.64, settling at an average of $52.04. This could translate to a +71.07% gain.
December 2026
Based on current market signals, Cue Biopharma, Inc. is projected to trend december 2026. We forecast a trading range from $58.06 to $76.87, with a likely average price of $67.04. Investors could expect a potential return of +120.38%.
January 2027
Our predictive algorithms indicate Cue Biopharma, Inc. stock may see a shift in January 2027. The expected range spans $36.34–$60.57, with an average target of $49.84. This represents a positive outlook and a possible gain of +63.84%.
February 2027
Analyzing established trends, Cue Biopharma, Inc. looks set to move in February 2027. Projections place the stock between $35.27 and $81.30, averaging around $52.13. This suggests a +71.37% gain from current levels.
March 2027
Market indicators suggest Cue Biopharma, Inc. could experience notable changes during March 2027. Prices could fluctuate within $46.56 to $67.41, with a midpoint forecast of $54.24. The stock might deliver a +78.30% gain.
April 2027
Forecasting for April 2027, models estimate that Cue Biopharma, Inc. may undergo key fluctuations. If trends hold, the stock might trade between $42.05 and $85.45, averaging $56.00. This signals a positive trajectory with potential returns around +84.09%.
CUE's history of dividends and stock splits also plays a role in long-term investor confidence.

